Search database
LIST OPTIONS
Filter
29
Filtered Results: 29
Text search: vaxzevria
Featured
Language
Document type
Guidelines
17
Fact sheets
7
Studies & Reports
4
No document type
1
Countries / Regions
Ukraine
3
Brazil
3
Latin America and the Carribbean
2
Germany
2
Authors & Publishers
World Health Organization WHO
12
OPAS
3
Organización Mundial de la Salud OMS
2
World Health Organisation (WHO)
2
Access to Medicine Foundation
1
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
European Centre for Disease Prevention and Control ECDC
1
European Medicines Agency EMA
1
Health Cluster, WHO
1
OPAS, OMS
1
Organisation Mondiale de la Santé OMS
1
Organización Panamericana de la Salud
1
Organização Mundial da Saúde (OMS)
1
PAHO
1
Pan American Health Organisation PAHO
1
Robert-Koch-Institut RKI
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
WHO
1
WHO Europe
1
World Health Organization WHO, Regional Office of Europe
1
Publication Years
Category
Countries
9
Clinical Guidelines
2
Pharmacy & Technologies
1
Toolboxes
COVID-19
22
Conflict
2
Refugee
1
Pharmacy
1
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc... more
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
7 April 2021
15 Dec 2021
21 January 2022 The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian... more
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp... more
interim guidance, 19 July 2021 (arabic version)
Recommendations for the adaptation of Emergency Medical Teams (EMTs) at temporary sites for COVID-19 vaccination. Draft Version 2.3, November 2021
Emergency medical teams (EMTs) play an important role in strengthening health service networks in terms of their strategies and tactics for planning mass vaccination programs, especially in remote or under-resourced areas or those overwhelmed by COVID-19. EMTs experience deploying in remote areas an... more
Weekly epidemiological update on COVID-19, 28 September 2022
Empfehlungen des Robert Koch-Instituts für Alten- und Pflegeeinrichtungen und Einrichtungen für Menschen mit Beeinträchtigungen und Behinderungen und für den öffentlichen Gesundheitsdienst Stand 7.4.2021
29 September 2021
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19) Interim guidance 19 July 2021
Orientations provisoires 19 juillet 2021